Trials / Unknown
UnknownNCT03734835
The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome
The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome and Its Components: A Randomized, Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the effects of Hesperidin, flaxseed and both together in patients with metabolic syndrome, 100 patients will be randomly allocated to one of following four groups: control group, hesperidin group (2 capsules Hesperidin), flaxseed group (30 gram flaxseed) or flaxseed-hesperidin group (2 capsules Hesperidin and 30 gram flaxseed) for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | hesperidin | 1000 mg hesperidin as two capsules |
| DIETARY_SUPPLEMENT | hesperidin and flaxseed | 1000 mg hesperidin as two capsules and 30 grams flaxseed |
| DIETARY_SUPPLEMENT | flaxseed | 30 grams flaxseed |
| OTHER | control | no supplementation |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2019-02-01
- Completion
- 2019-03-01
- First posted
- 2018-11-08
- Last updated
- 2018-11-08
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03734835. Inclusion in this directory is not an endorsement.